For the full year, revenue (continuing operations) declined 2 per cent on a constant currency basis. There was a positive contribution from European corrugated box volumes (£22 million) and an incremental c. nine month contribution from Europac (which was acquired in mid January 2019) of £376 million, offset in Europe by reduced pricing of external paper, recyclate and box prices (together down £285 million year on year), and a decline in other volumes particularly due to increased paper and recyclate integration and reduced volumes of corrugated sheet (down £175 million). The reduced sales price across the European operations was driven principally by a fall in testliner and kraftliner pricing, which partly fed through into corrugated packaging pricing progressively through the year as indexed contracts adjusted for the market price of paper, the main input cost. The North America business also recorded a fall in revenue (down £63 million), principally reflecting lower paper prices into the export market. Operating profit improved 6 per cent (constant currency) to £455 million (2018/19: £427 million).

Cascades announces an important repositioning of its Tissue Papers platform to enhance the performance of the business. The Company will simplify operations by concentrating the majority of its tissue product operating activities at core, geographically well-positioned sites that offer opportunities for future development. These changes will reduce costs, create synergies and significantly improve the Tissue Group’s financial, operational and environmental performance. This decision will not affect the level of service Cascades provides to its customers. Beginning in July 2023, Cascades will progressively close its underperforming plants in Barnwell, South Carolina, and Scappoose, Oregon, as well as the virgin paper tissue machine at its St. Helens plant, also in Oregon. The equipment slated for closure, which have a combined total annual rated capacity of 92,000 short tons of tissue paper and 10 million cases of converted product, have been operating below capacity producing 56,000 short tons of tissue paper and 5 million cases of converted product in 2022, mostly on the West coast. A portion of this production will be absorbed by open capacity at our other facilities and by the increase in productivity at our sites, particularly in the United States. Cascades has the option to evaluate the possibility of redeploying the seven conversion lines impacted by this decision to other sites at a later date.

Sonoco announced it will raise the price for all paperboard tubes and cores by a minimum of 6 percent, effective with shipments in the United States and Canada, on or after May 24, 2021. “This price increase is necessary due to continued increases in costs for uncoated recycled paperboard (URB), our primary raw material which remains in very tight supply. Additionally, we are feeling significant inflationary pressures in adhesives, packaging and logistics costs,” said Mike Thompson, Director of Sales and Marketing for Sonoco’s North America Tubes and Cores Division.